1201P Evaluation of Efficacy TEMCAP Regiment As First-Line or Further Line Therapy in Patients with Advanced, Unresectable, Progressive GEP-NET. Real-world Data
Annals of Oncology（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology（2023）